Oct 16th, Hainan, China—The 15th Award of competitive and trustworthy listed companies in China was held in Sanya, Hainan. The theme of the forum was “the prospect of the capital market driven by the ‘double cycle’”. The attendees included experts and KOL from different industries and entrepreneurs from hundreds of successful listed companies. They gathered together to discuss risks, opportunities and expectations of the capital market under the influence of COVID-19.
Medicilon was invited as a newly successful listed company. At the event, Medicilon won “The best sustainable investable listed company Award”. Meanwhile, Mr. Wang Guolin, Secretary of the board of directors of the company, won the “gold medal Secretary of the board directors”. The award acknowledged the market performance and strategies Medicilon had had in the past. In the future, Medicilon, as the leading CRO for new drug research and development, will further develop and expand with the help of capital market and keep “Innovation Driven, Quality Focused”.